Author

Damien Gaillard

Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

Jérémy Verchère· 2 shared Thierry BaroniD· 2 shared Anna SalvettiiD· 1 shared Aude Decesar· 1 shared Benjamin VidaliD· 1 shared Chloé Dure· 1 shared Claire Aufauvre· 1 shared Dominique Bétemps· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Jérémy Verchère

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Behavioural, biochemical and functional phenotyping of chronic exposure to chlordecone in mice

Johann Vulin, Fabien Chauveau, Chloé Dure, Muris Humo, Marco Valdebenito, Claire Aufauvre, Louis Vidal, Eric Morignat, Jérémy Verchère, Aude Decesar, Damien Gaillard, Latifa Lakdhar, Thierry Baron, Gwenaëlle Lavison‐Bompard, Benjamin Vidal

This study examines the effects of subchronic chlordecone exposure in mice, finding minimal behavioral impact but altered visual response detected by functional ultrasound imaging.

bioRxiv · Jun 16, 2025 · PreprintNeuroscience

Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy

Dorian Sargent, Dominique Bétemps, Matthieu Drouyer, Jérémy Verchère, Damien Gaillard, Jean-Noël Arsac, Latifa Lakhdar, Anna Salvetti, Thierry Baron

This study investigates whether β-synuclein overexpression via AAV can inhibit α-synuclein aggregation in a synucleinopathy model, but finds no delay in disease onset and reports specific β-synuclein aggregates in treated mice.

Scientific Reports · Nov 27, 2018Peer-reviewedNeuroscience